Browser storage is unavailable. Keep this page open and export your collection before leaving.
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designe
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
Previously Menten Biotechnology Labs, Inc.
TechBio startup founder with hands-on operational and finance experience. Working at the intersection of chemistry, biology, and computer science. Passionate about investing and value creation in the Life Science ecosystem. Outside of work, I enjoy several different sports activities, such as scuba diving, surfing, MTB, wakeboarding, and have 10 years of triathlon experience.
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
abinitio bio is the AI-native operating platform for drug development and manufacturing.
Founders · Product · How it works
Same category · Biotech pharma
Our autonomous biodefense capabilities ensure validated point-of-care diagnostics for emerging biological threats are developed in days, not 12+ months.
Founders
Same category · Biotech pharma
Anthrogen is engineering post-modality biology. Today's modalities reflect historical contingencies in biological progress, not fundamental categories. We develop the AI systems that design modular biological machines and the…
Founders · Product
Same category · Biotech pharma
Anto is building a foundation model for microbial communities, making the gut microbiome computable for the first time. We predict drug toxicity and efficacy across diverse populations and fix drugs so they work for everyone — solving…
Founders · Product
Same category · Biotech pharma
Generative AI Medical Writing Solution for Biotech, Life Sciences, Pharma & Medical Devices | Artos AI. Book a demo online.
Customers · Founders · Product
Same category · Biotech pharma
Astraea is AI software for clinical trial teams. Build SDTM, ADaM and TFL outputs in your environment, with qualified experts reviewing every output.
Founders · Product · How it works
Same category · Biotech pharma
